Autor: |
Michal Pechar, Robert Pola, Martin Studenovský, Markéta Bláhová, Eliška Grosmanová, Aneta Dydowiczová, Marcela Filipová, Rayhanul Islam, Shanghui Gao, Jun Fang, Tomáš Etrych |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Nanomedicine: Nanotechnology, Biology and Medicine. 46:102597 |
ISSN: |
1549-9634 |
DOI: |
10.1016/j.nano.2022.102597 |
Popis: |
Polymer nanomedicines with anti-tumor activity should exhibit sufficient stability during systemic circulation to the target tissue; however, they should release the active drug selectively in the tumor. Thus, choice of a tumor-specific stimuli-sensitive spacer between the drug and the carrier is critical. Here, a series of polymer conjugates of anti-cancer drugs doxorubicin and pirarubicin covalently bound to copolymers based on N-(2-hydroxypropyl)methacrylamide via various enzymatically cleavable oligopeptide spacers were prepared and characterized. The highest rate of the drug release from the polymer carriers in presence of the lysosomal protease cathepsin B was determined for the copolymers with Val-Cit-Aba spacer. Copolymers containing pirarubicin were more cytotoxic and showed higher internalization rate than the corresponding doxorubicin counterparts. The conjugates containing GFLG and Val-Cit-Aba spacers exhibited the highest anti-tumor efficacy in vivo against murine sarcoma S-180, the highest rate of the enzymatically catalyzed drug release, and the highest cytotoxicity in vitro. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|